S-44858

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameS-44858
Drug Alias NameS-44858
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA modulatorsGlutamate [NMDA] receptor subunit epsilon 2 antagonists
TargetsGlutamate receptor ionotropic AMPAGlutamate [NMDA] receptor subunit epsilon 2
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesLes Laboratoires Servier
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A